CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,546,000 | -21.8% | 357,134 | -8.0% | 0.00% | -100.0% |
Q3 2021 | $1,977,000 | +5.6% | 388,320 | +31.3% | 0.00% | 0.0% |
Q2 2021 | $1,872,000 | -17.4% | 295,718 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $2,266,000 | +35.1% | 293,183 | +14.5% | 0.00% | 0.0% |
Q4 2020 | $1,677,000 | -2.4% | 255,965 | -1.0% | 0.00% | 0.0% |
Q3 2020 | $1,719,000 | +1.3% | 258,535 | +26.9% | 0.00% | 0.0% |
Q2 2020 | $1,697,000 | +5.9% | 203,735 | -2.5% | 0.00% | 0.0% |
Q1 2020 | $1,602,000 | +9.7% | 208,925 | +18.8% | 0.00% | 0.0% |
Q4 2019 | $1,461,000 | +1.6% | 175,856 | -9.8% | 0.00% | 0.0% |
Q3 2019 | $1,438,000 | – | 194,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |